A recent study utilized next-generation sequencing (NGS) to distinguish between hepatitis C virus (HCV) reinfection and relapse in six patients who achieved sustained virologic response (SVR) after direct-acting antiviral (DAA) treatment.
NGS Study Differentiates HCV Reinfection from Relapse Post-DAA Treatment Using Z-scores and Genetic Analysis
Tori Gustafson2024-04-03T16:57:20+00:00April 3rd, 2024|hepatitis C|Comments Off on NGS Study Differentiates HCV Reinfection from Relapse Post-DAA Treatment Using Z-scores and Genetic Analysis